Nelfinavir
Back to searchMolecule Structure
Scientific Name
Nelfinavir
Description of the Drug
Nelfinavir is a viral protease inhibitor used in the treatment of HIV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00220
http://www.drugbank.ca/drugs/DB00220
Brand Name(s)
Not Available
Company Owner(s)
Agouron Pharmaceuticals Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL38218 | ||
PharmGKB | PA450606 | ||
Human Metabolome Database | HMDB0014365 | ||
DrugBank | DB00220 | ||
PubChem: Thomson Pharma | 14862000 | 14886478 | |
PubChem | 64143 | ||
LINCS | LSM-5819 | ||
Nikkaji | J1.642.472B | ||
PDBe | 1UN | ||
BindingDB | 50061306 | 518 | |
EPA CompTox Dashboard | DTXSID5035080 | ||
DrugCentral | 1893 | ||
Brenda | 1193 | 229722 | 229723 |
ChemicalBook | CB8213806 | ||
Guide to Pharmacology | 11090 | ||
rxnorm | VIRACEPT | NELFINAVIR | NELFINAVIR MESYLATE |
KEGG Ligand | C07257 | ||
ChEBI | 7496 | ||
ZINC | ZINC000003833846 |